索托拉西布（Lumakras）：患者需要了解什麼？ – Oncodaily
索托拉西布（Lumakras）：患者需要了解什麼？
正文內容
Sotorasib (Lumakras) treats KRAS G12C-mutated cancers. Learn about uses, dosage, side effects, and expectation during treatment for patients, cancer treatment, Colorectal Cancer (CRC), Drugs, FDA Approved drugs, Lung cancer, NSCLC, OncoDaily, Oncology, Sotorasib
文章相關商品
系統已根據文章標題、摘要和正文，自動匹配目前在售的強相關藥品。
索托拉西布錠 SOTOLDX Sotorasib 120mg
2021年5月29日，美國FDA宣布加速核准索拓拉西AMG510（Sotorasib）上市，用於治療腫瘤攜帶KRAS G12C突變的非小細胞肺癌（NSCLC）病患。這些患者至少接受過一種前期全身性治療。這是全球首款針對特定KRAS基因突變的抗癌療法。
查看商品
常見問題
Which products are related to this article?
The system matched these relevant products from the article content: 盧修斯 索托拉西布 Sotorasib 在線購買、索托拉西布錠 SOTOLDX Sotorasib 120mg.
How can I view the medicines discussed in this article?
Use the related product cards below the article to review available specifications, prices, product information, and reviews.
Does this article replace advice from a doctor or pharmacist?
No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.
